Results 221 to 230 of about 2,746,854 (288)

Transforming psychological practice with precision mental health: introduction to the NOVA project. [PDF]

Front Psychol
Roca P, Noheda S, Ramírez-Riveros E, Martín-Azañedo C, Martínez-Zaragoza F, Zangri RM, García Del Valle EP, Sanchez-Pedreño M, León-Garcia M, Gravholt DL, Enrique A, Saunders R, Herrera LJ, Pegalajar MDC, Vázquez C, Rodriguez-Moreno S.   +15 more
europepmc   +1 more source

Global purchasing strategy: Conceptualization and measurement. [PDF]

Matthyssens, Paul, Pauwels, Pieter, Quintens, Lieven   +2 more
core   +1 more source

Prognostic Impact of European LeukemiaNet Genetic Risk Stratification System in Adult Patients With Acute Myeloid Leukemia

Aging and Cancer, EarlyView.
This study aimed to evaluate the prognostic value of ELN2017 in predicting survival outcomes and to assess the impact of clinical and molecular factors such as age, FLT3 and NPM1 mutations, and allogeneic hematopoietic stem cell transplantation (allo‐HSCT).
Mobina Shrestha, Bishwas Mandal, Vishal Mandal, Asis Shrestha, Amir Babu Shrestha   +4 more
wiley   +1 more source

The role of large immune complexes in anti-drug antibody development: a case study of anti-SARS-CoV-2 antibody therapeutics and co-administered mRNA vaccine. [PDF]

Front Immunol
Irvin SC, Wang Z, Ganguly S, Choudhary D, Kanagaraj M, Liu N, Isa F, He ZW, Yan H, Casullo VM, Turner KC, Davis JD, Rosconi MP, Torri A, Partridge MA.   +14 more
europepmc   +1 more source

Long‐Term Follow‐Up of Chemotherapy‐Associated Biological Aging in Women With Early Breast Cancer

Aging and Cancer, EarlyView.
Women threated with adjuvant chemotherapy for early breast cancer have sustained long‐term increase in p16INK4a,, a robust marker of cell senescence, suggesting a chemotherapy‐associated age acceleration. p16INK4a as well as other biomarkers may identify patients at greatest risk for senescence‐related diseases of aging.
Hyman B. Muss, Alexis C. Wardell, Allison M. Deal, Kirsten A. Nyrop, Allison Ross, Yara G. Abdou, Jeffrey D. Aldrich, Lisa A. Cary, E. Claire Dees, Katherine E. Reeder‐Hayes, Emily M. Ray, Natalia Mitin, Denis Tsygankov   +12 more
wiley   +1 more source

Preliminary report on advanced biliary cancer patients receiving multimodality treatment in the immunotherapy era: a real-world multicentre experience. [PDF]

Ther Adv Med Oncol
Salati M, Borghi E, Cuoghi Costantini R, Parisi A, Lancianese A, Palloni A, Ricci C, Garajova I, Orlandi E, Zurlo IV, Petrillo A, Diana A, Ricci AD, Rizzo A, Manni M, Garrone O, Dominici M, Ghidini M.   +17 more
europepmc   +1 more source

Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To characterise the progression of motor symptoms and identify eligibility for device‐aided therapies in Parkinson's disease, using both the 5‐2‐1 criteria and a refined clinical definition, while examining differences across genetic subgroups.
David Ledingham, Sahana Sathyanarayana, Charlotte B. Stewart, Robyn Iredale, Victoria Foster, Debra Galley, Mark Baker, Nicola Pavese   +7 more
wiley   +1 more source

Comment on: Pettersson et al. Qdenga-induced dengue caused by minor DENV-2 subvariant(s) in the vaccine, with two amino acid substitutions in the E protein. [PDF]

J Travel Med
Tricou V, Livengood J, Sharma M, Zent O, Rauscher M, Setoh YX, Brünner C, Biswal S, Kandeil W.   +8 more
europepmc   +1 more source